Dynamic analysis and optimal control of COVID-19 with comorbidity: A modeling study of Indonesia

Author:

Rois Muhammad Abdurrahman,Fatmawati ,Alfiniyah Cicik,Chukwu Chidozie W.

Abstract

Comorbidity is defined as the coexistence of two or more diseases in a person at the same time. The mathematical analysis of the COVID-19 model with comorbidities presented includes model validation of cumulative cases infected with COVID-19 from 1 November 2020 to 19 May 2021 in Indonesia, followed by positivity and boundedness solutions, equilibrium point, basic reproduction number (R0), and stability of the equilibrium point. A sensitivity analysis was carried out to determine how the parameters affect the spread. Disease-free equilibrium points are asymptotically stable locally and globally if R0 < 1 and endemic equilibrium points exist, locally and globally asymptotically stable if R0 > 1. In addition, this disease is endemic in Indonesia, with R0 = 1.47. Furthermore, two optimal controls, namely public education and increased medical care, are included in the model to determine the best strategy to reduce the spread of the disease. Overall, the two control measures were equally effective in suppressing the spread of the disease as the number of COVID-19 infections was significantly reduced. Thus, it was concluded that more attention should be paid to patients with COVID-19 with underlying comorbid conditions because the probability of being infected with COVID-19 is higher and mortality in this population is much higher. Finally, the combined control strategy is an optimal strategy that provides an effective guarantee to protect the public from the COVID-19 infection based on numerical simulations and cost evaluations.

Publisher

Frontiers Media SA

Subject

Applied Mathematics,Statistics and Probability

Reference59 articles.

1. Novel Coronavirus2020

2. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese center for disease control and prevention;Wu;JAMA,2020

3. Pertanyaan dan Jawaban Terkait COVID-19 Kementerian Kesehatan2020

4. Novel Coronavirus (COVID-19)2021

5. Novel Coronavirus2020

Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3